American Vietnamese Biotech INC (HNX: AMV)
3,300
Open3,300
High3,400
Low3,200
Vol441,914
Market Cap.432.65
Remain Bid1,618,686
Remain Ask1,526,186
52Wk High5,500
52Wk Low3,100
52Wk Avg Vol1,680,364
Foreign Buy-
Frgn Owned(%)-
Dividend
Dividend Yield-
Beta1.16
EPS115
P/E28.74
F P/E3.09
BVPS12,889
P/B0.26
- Overview
- Trading
- Technical Analysis
- Financials
- Profile
- News & Events
- Industry Peers
- Documents
- Internal Trading
- Bonds
| Date | Close | Change | Volume |
|---|---|---|---|
| 05/08/2024 | 3,300 | 0 (0.00%) | 441,914 |
| 05/07/2024 | 3,300 | 0 (0.00%) | 936,052 |
| 05/06/2024 | 3,300 | 100 (+3.13%) | 272,912 |
| 05/03/2024 | 3,200 | 0 (0.00%) | 225,566 |
| 05/02/2024 | 3,200 | 100 (+3.23%) | 466,331 |
| 04/05/2022 | AMV Buying addition shares with 43.90% and VND10,000/share |
| 01/11/2021 | AMV Dividend payment in cash with 10.00% (Tranche 1/2019) |
| 01/11/2021 | AMV Dividend payment in cash with 10.00% (Tranche 1/2019) (Record date) |
| 01/11/2021 | AMV Dividend payment in cash with 10.00% (Tranche 2/2019) |
| 01/11/2021 | AMV Dividend payment in cash with 10.00% (Tranche 2/2019) (Record date) |
| 05/06/2024 | Explanation for Parent Company FS Quarter 1 of 2024 |
| 05/06/2024 | Parent Company FS Quarter 1 of 2024 |
| 05/06/2024 | Explanation for Consolidated FS Quarter 1 of 2024 |
| 05/06/2024 | Consolidated FS Quarter 1 of 2024 |
| 04/17/2024 | Annual report 2023 |
Name: American Vietnamese Biotech INC
Abbreviation:AMVIBIOTECH INC
Address: Floor 4, Phu Ma Duong Building, No.85 Hoang Van Thai Street, Tan Phu ward District 7 Ho Chi Minh
Telephone: (84.651) 388 9034
Fax: (84.651) 388 9032
Email:amvibiotechinc@gmail.com
Website:https://amvibiotech.com
Exchange: HNX
Sector: Manufacturing
Industry: Miscellaneous Manufacturing
Listing date: 12/30/2009
Chartered capital: 1,311,056,500,000
Listed shares: 131,105,650
Shares outstanding: 131,105,650
Status: Operating
Tax code: 3800237998
Establishment license: 4403000012
Issued date: 08/26/2002
Business license: 3800237998
Issued date: 08/26/2002
Main business scope:
- Trading pharmaceutical products, medical equipments, tools and chemicals.
- Producing and trading vaccine and medical products.
- Real estate services.
- Financial investment.
- Other under business lience.
- August 26, 2002: American Vietnamese Biotech Incorporation was established by three founders with charter capital of VND15 billion.
- 2003: Constructing its manufactory with the square of 1,500 m2 in Dong Xoai town, Binh Phuoc Province;
- July 2005: The manufactory was appraised and licensed by Medical Ministry;
- August 2005: AMV began producing and trading products;
- 2006: AMV established a distribution network in the Northern, Middle and Southern through agents.
- April 2007: The company raised its charter capital to VND21 billion;
- December 20, 2009: Traded on Hanoi Stock Exchange (HNX);
- June 26, 2017: Charter capital was raised up to VND271,157,500,000;
- January 20, 2020: Increased charter capital to VND379,620,450,000;
- March 22, 2021: Increased charter capital to VND531,486,160,000;
- April 12, 2021: Increased charter capital to VND911,088,610,000;
- 06/28/2023 AMV General Meeting of Shareholders for 2023
- 06/07/2023 AMV Annoucement of the change of listing - 28,512,044 shares
- 07/19/2022 AMV Annoucement of the change of listing - 11,484,745 shares
- 07/05/2022 AMV Decision on the change of listing - 39,996,789 shares
- 06/29/2022 AMV General Meeting of Shareholders for 2022
| Items | Unit |
|---|---|
| Price | VND |
| Volume | Shares |
| Foreigner's, Yield | % |
| Mkt Cap | bVND |
| Financial indicators | mVND |
| EPS, BVPS, Dividend | VND |
| P/E, F P/E, P/B | Times |
| ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
